Search by keywords: Connect with us Stay Informed. Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters. Newsletter Sign Up 101 News Items found MSK Radiation Oncologists: More Research Needed to Support Use of Immunotherapy in Locally Advanced Head and Neck Cancer Tuesday, May 11, 2021 MSK experts co-authored a piece in Targeted Oncology about the findings from a recent clinical trial. 5 Reasons Boys and Young Men Need the HPV Vaccine, Too Thursday, June 10, 2021 If you think women are the only people who get cancers caused by the human papillomavirus (HPV), think again. These cancers are on the rise in men. New Throat Cancer Treatments Aim To Reduce Deaths and Preserve Function in 2025 and Beyond Thursday, September 4, 2025 Learn how MSK's world-class Head and Neck cancer specialists help people facing throat cancer, using the latest therapies and innovations. MSK-Led Research Resulted in New FDA Approvals for Cancer Drugs in 2025 Monday, December 15, 2025 Learn about the clinical trials and research at MSK that led to FDA approvals in 2025, expanding treatment options for a range of different cancers. New MSK Radiation Approach Means Fewer Side Effects for More Patients with HPV-Related Head and Neck Cancer Thursday, January 20, 2022 A low-dose radiation approach could help more patients avoid side effects of treatment for head and neck cancer. In the Clinic Avoiding Surgery for HPV Throat Cancer May Be Possible for More Patients Friday, September 20, 2024 Learn how HPV-related head and neck cancer can be treated with a sharply reduced radiation dose to prevent side effects, sometimes without surgery. Announcement MSK Issues Joint Statement Urging Use of HPV Vaccine to Prevent Cancers Wednesday, January 27, 2016 MSK joins other leading cancer institutions in calling for increased vaccination to protect against human papillomavirus, which causes many forms of cancer. Clinical Update Pembrolizumab for Locally Advanced Head and Neck Squamous Cell Carcinoma Approved by the FDA for Use Before and After Surgery Wednesday, October 1, 2025 Read about an FDA approval for immunotherapy to treat head and neck squamous cell carcinoma. ASTRO 2025 Highlights From MSK Wednesday, October 1, 2025 Learn about some of the exciting research that MSK doctors and scientists presented at the 2025 Annual Meeting of the American Society for Radiation Oncology. HPV Vaccine Age Limit: You Might Not Be Too Old — What You Should Know Friday, February 28, 2025 Learn from MSK experts what people over 26 should know about getting the HPV vaccine to protect themselves from several forms of cancer. Pagination First page « First Previous page ‹ Previous Page 1 Current page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next page Next › Last page Last » Book traversal links for Newsroom Previous Newsroom Next Cancer Vaccine Could Prevent Neuroblastoma From Returning After Antibody Treatment